LOS ANGELES, Apr 28, 2009 (UPI via COMTEX) -- Pomegranate juice may slow the
progress of recurring prostate cancer, U.S. and Israeli researchers say.
The two-stage clinical trial tracked 48 men over six years who had had rising
prostate specific antigen scores after surgery or radiation. They were told to
drink eight ounces of pomegranate juice daily.
The decline in median PSA slope was greater among those still drinking the juice
after six years compared to a "non-active" group that had begun with similar
baseline PSAs.
Researchers from the David Geffen School of Medicine, at the University of
California, Los Angeles, and the Rambam Medical Center in Haifa, Israel,
presented the findings at the annual scientific meeting of the American
Urological Association in Chicago.
"This study suggests that pomegranate juice may effectively slow the progression
of prostate cancer after unsuccessful treatment," Dr. Christopher Amling,
spokesman for the American Urological Association, said in a statement. "This
finding and other ongoing research might one day reveal that pomegranate juice
is an effective prostate cancer preventative agent as well."
URL: www.upi.com
Copyright 2009 by United Press International